Status:
UNKNOWN
Pitavastatin on Carotid Intima-media Thickness
Lead Sponsor:
Kyoto Prefectural University of Medicine
Conditions:
Hyperlipidemia
Carotid Artery Diseases
Eligibility:
All Genders
20-80 years
Phase:
NA
Brief Summary
This study is aimed to analyze the effects of aggressive and conventional lipid lowering therapy with Pravastatin on carotid intima-media thickness (IMT) in patients with hyperlipidemia and abnormal t...
Eligibility Criteria
Inclusion
- Diagnosed as having hyperlipidemia
- LDL-C at the time of enrollment is no less than 100
- Common carotid IMT is 1.1 mm and over
Exclusion
- Received or planned to receive intervention on carotid arteries during the study period
- Overt liver dysfunction (ALT; 100 IU/L and over)
- Overt renal dysfunction (serum creatinine; 2.0 mg/dL and over)
- Receiving Cyclosporin
- Hyperreactive to Pitavastatin
- During pregnancy or lactation
Key Trial Info
Start Date :
July 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00711919
Start Date
July 1 2007
Last Update
September 10 2009
Active Locations (18)
Enter a location and click search to find clinical trials sorted by distance.
1
Ayabe City Hospital
Ayabe, Kyoto, Japan, 623-0011
2
Fukuchiyama City Hospital
Fukuchiyama, Kyoto, Japan, 620-8505
3
Saiseikai Kyoto Hospital
Kōtari, Kyoto, Japan, 617-0814
4
Takeda Hospital
Kyoto, Kyoto, Japan, 600-8558